hydrazones, the cyclization reaction slower, providing 5 in poor
yields with additional formation of 4.
C. O. de Ocariz, Mini-Rev. Med. Chem., 2005, 5, 869–878; (d) M. De
Angelis, F. Stossi, K. A. Carlson, B. S. Katzenellenbogen and J. A.
Katzenellenbogen, J. Med. Chem., 2005, 48, 1132–1144.
In conclusion, we have developed a facile, efficient route to 1,3,4-
benzotriazepine and 1H-indazole derivatives by the palladium-
catalyzed cyclization reaction of readily available aryl hydrazones
and aryl isocyanates under microwave irradiation. These condi-
tions are applicable to the cyclization of a wide variety of aryl
hydrazones and aryl isocyanates, and enable the rapid construction
of diverse arrays of 1,3,4-benzotriazepines and 1-arylamide-1H-
indazoles in a library-like fashion. Notably, these heterocycles are
core synthons for many pharmaceutical products. Efforts to study
their biological activity further are under way.
3 L. V. Popova, S. V. Vlasyuk, V. I. Pavlovs’kii and T. L. Karas’ova,
Farmatsevtichnii Zhurnal, 2002, 2, 89–92.
4 (a) F. R. Alexandre, A. Berecibar, R. Wrigglesworth, L. Perreux, J.
Guillon, J. M. Leger, V. Thiery and T. Besson, Tetrahedron, 2005, 61,
8288–8294; (b) Z. Jalal A., E. Mustafa M., A. T. Bassam A., L. Stefan
and B. Roland, Heterocycles, 2008, 75, 2989–3004; (c) G. I. K. S. E.
Ivanova, Zh. Org. Khim., 1995, 31, 1601–1616.
5 (a) A. Schmidt, A. Beutler and B. Snovvdovych, Eur. J. Org. Chem.,
2008, 4073–4095; (b) N. F. Sandra, F. Joan-Carles, F. Pilar, E.
Paul and A. Fernando, QSAR Comb. Sci., 2008, 27, 1267–1273;
(c) N. Haddad and J. Baron, Tetrahedron Lett., 2002, 43, 2171–2173;
(d) M. Y. Watanabe Toshihide and Nishiyama Masakazu., Angew.
Chem., Int. Ed., 2000, 39, 2501–2504.
6 (a) J. J. Song and N. K. Yee, Org. Lett., 2000, 2, 519–521; (b) K.
Inamoto, M. Katsuno, T. Yoshino, Y. Arai, K. Hiroya and T. Sakamoto,
Tetrahedron, 2007, 63, 2695–2711; (c) S. P. McClintock, N. Forster, R.
Herges and M. M. Haley, J. Org. Chem., 2009, 74, 6631–6636; (d) G. L.
Dou and D. Q. Shi, J. Comb. Chem., 2009, 11, 1073–1077.
7 C. S. L. Cho, K. Dong, N. H. Heo, T. J. Kim and S. C. Shim, Chem.
Commun., 2004, 104–105.
Acknowledgements
This work is supported by National Nature Science Foundation
of China (20972121, 20872116), the Science Foundation of
Ministry of Education for the New Teacher at the University
of China (20090141120058), the Important National Science &
Technology Specific Projects (No. 2009ZX09301-14), and the
startup fund from Wuhan University (Grant 306276315). Prof.
John A. Katzenellenbogen is thanked for critical reading of this
manuscript. Professor Haibing Zhou is acknowledged for helpful
discussions. We also thank Prof. Guofu Qiu for the measurement
of NMR.
8 A. Y. Lebedev, A. S. Khartulyari and A. Z. Voskoboynikov, J. Org.
Chem., 2005, 70, 596–602.
9 (a) D. M. D’Souza and T. J. J. Muller, Chem. Soc. Rev., 2007, 36, 1095–
1108; (b) F. Bellina and R. Rossi, Chem. Rev., 2010, 110, 1082–1146.
10 (a) S. Diez-Gonzalez, N. Marion and S. P. Nolan, Chem. Rev., 2009, 109,
3612–3676; (b) O. Daugulis, H. Q. Do and D. Shabashov, Acc. Chem.
Res., 2009, 42, 1074–1086; (c) K. C. Majumdar and B. Chattopadhyay,
Curr. Org. Chem., 2009, 13, 731–757; (d) R. Martin and S. L. Buchwald,
Acc. Chem. Res., 2008, 41, 1461–1473.
11 (a) C. Dong and H. Alper, Org. Lett., 2004, 6, 3489–3492; (b) C. Dong
and H. Alper, J. Org. Chem., 2004, 69, 5011–5014; (c) C. Dong and H.
Alper, Tetrahedron: Asymmetry, 2004, 15, 35–40.
12 C. Dong and H. Alper, Tetrahedron: Asymmetry, 2004, 15, 1537–1540.
13 (a) A. de Meijere and F. Diederich, Metal-Catalyzed Cross-Coupling
Reactions, 2nd edn, Wiley-VCH, New York, 2004; (b) M. Beller and C.
Bolm,Transition Metals for Organic Synthesis, Wiley-VCH, New York,
1998; (c) J. Tsuji, Palladium Reagents and Catalysis, Wiley, New York,
1995.
14 (a) A. Shiozawa, K. Narita, G. Izumi, S. Kurashige, K. Sakitama and
M. Ishikawa, Eur. J. Med. Chem., 1995, 30, 85–94; (b) S. R. Stauffer, Y.
Huang, C. J. Coletta, R. Tedesco and J. A. Katzenellenbogen, Bioorg.
Med. Chem., 2001, 9, 141–150.
15 (a) C. O. Kappe, Angew. Chem., Int. Ed., 2004, 43, 6250 and references
therein; (b) F. Mavandadi and P. Lidstrom, Curr. Top. Med. Chem.,
2004, 4, 773; (c) M. Larhed, C. Moberg and A. Hallberg, Acc. Chem.
Res., 2002, 35, 717; (d) B. Wathey, J. Tierney, P. Lidstrom and J.
Westman, Drug Discovery Today, 2002, 7, 373; (e) S. Caddick and
R. Fitzmaurice, Tetrahedron, 2009, 65, 3325–3355.
Notes and references
1 (a) M. D. Burke, E. M. Berger and S. L. Schreiber, Science, 2003, 302,
613–618; (b) J. Bonjoch and D. Sole, Chem. Rev., 2000, 100, 3455–3482;
(c) M. Bradley and L. Weber, Curr. Opin. Chem. Biol., 2000, 4, 255–
256; (d) H. L. Fu, C. Dennis, Shala L. Thomas and James P. Snyder,
PCT Int. Appl., 2008, 122pp; (e) O. Morgenstern, Pharmazie, 2000, 55,
871–891.
2 (a) I. M. McDonald, C. Austin, I. M. Buck, D. J. Dunstone, E. Griffin,
E. A. Harper, R. A. D. Hull, S. B. Kalindjian, I. D. Linney, C. M. R.
Low, M. J. Pether, J. Spencer, P. T. Wright, T. Adatia and A. Bashall,
J. Med. Chem., 2006, 49, 2253–2261; (b) I. M. McDonald, C. Austin,
I. M. Buck, D. J. Dunstone, J. Gaffen, E. Griffin, E. A. Harper, R. A. D.
Hull, S. B. Kalindjian, I. D. Linney, C. M. R. Low, D. Patel, M. J.
Pether, M. Raynor, S. P. Roberts, M. E. Shaxted, J. Spencer, K. I. M.
Steel, D. A. Sykes, P. T. Wright and W. Xun, J. Med. Chem., 2007, 50,
4789–4792; (c) H. Cerecetto, A. Gerpe, M. Gonzalez, V. J. Aran and
4830 | Org. Biomol. Chem., 2010, 8, 4827–4830
This journal is
The Royal Society of Chemistry 2010
©